New York-based Cleerly Labs Inc., petitioned several U.S. Medicare administrative contractors for coverage of the use of the company’s artificial intelligence product for analysis of CT coronary arteries to evaluate the disease burden of plaque.
The Parliament of the U.K. has dissolved right on schedule, leaving the members of the House of Commons with a raft of policy issues to deal with in the next assembly. One of these issues is a bill originating in the House of Lords, the Artificial Intelligence Bill, which seems technologically agnostic and thus may represent a risk of duplicative oversight of AI for health care purposes.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Artelon, Burning Rock, Coagco, Genialis, Highlife, Microbot Medical, Stryker, Ultrasight.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brainsway, Venus Concept.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Innovoyce, Watmind.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cydar, Johnson & Johnson, Shockwave, Sharps Technology, Nephron, Personalis, Tempus.
RSS
